American HealthCare Capital is pleased to introduce a highly profitable specialty pharmacy for sale in Texas. This well-established company has a long-standing presence and outstanding reputation within the local communities they serve. The specialty pharmacy focuses on Rheumatology, Dermatology, G.I. diseases, Hypercholesterolemia, Viral Hepatitis, and Osteoporosis. Although they have focused primarily on serving Texas thus far, they are licensed in a total of 31 states, which could be a source of major growth.
The pharmacy accepts all major payers, including Medicare, Medicaid, and private insurance. They have been able to achieve rapid growth within the last few years, with gross revenues of around $22 million in 2017 and $31 million in 2018. They are projecting gross revenues of $36 million in 2019 with an adjusted EBITDA of $1.5 million (4.7%) and an average script count of 1,000 per month.
There is a full complement of staff that is expected to stay on post-acquisition. The sellers would like to pursue other business ventures but will assist during a transitional period as needed. The asking price for this opportunity is $12 Million plus the cost of inventory.
